Thank you for agreeing to participate in our research study! As previously mentioned, your responses are confidential. Your name is never used, and your responses are used for research purposes only.
In this study we will be exploring health care professionals’ experiences with oncology treatments in Multiple Myeloma (and other cancers) that have different modes of administration: Velcade, Rituxan, Darzalex, etc. We’ve randomly assigned one treatment to each healthcare professional in this study. The treatment we will have you focus on is DARZALEX.
If you have any questions, please contact the individual who recruited you to participate. Please complete at least 24 hours prior to your scheduled interview.